3.連結財務諸表及び主な注記
(1)連結貸借対照表
| | (単位:百万円) |
| 前連結会計年度 (2025年7月31日) | 当連結会計年度 (2026年7月31日) |
資産の部 | | |
流動資産 | | |
現金及び預金 | 4,655 | 4,951 |
売掛金 | 1,421 | 1,171 |
製品 | 1,002 | 1,107 |
原材料及び貯蔵品 | 457 | 550 |
前払費用 | 214 | 189 |
その他 | 321 | 326 |
流動資産合計 | 8,073 | 8,297 |
固定資産 | | |
有形固定資産 | | |
建物(純額) | 414 | 437 |
車両運搬具(純額) | 0 | 4 |
工具、器具及び備品(純額) | 138 | 116 |
有形固定資産合計 | 553 | 559 |
無形固定資産 | | |
のれん | 310 | 268 |
特許権 | 169 | 151 |
ソフトウエア | 373 | 293 |
ソフトウエア仮勘定 | 21 | 53 |
その他 | 39 | 36 |
無形固定資産合計 | 914 | 802 |
投資その他の資産 | | |
投資有価証券 | 18 | 18 |
長期前払費用 | 13 | 6 |
繰延税金資産 | 81 | 96 |
敷金 | 460 | 445 |
その他 | 63 | 55 |
貸倒引当金 | △37 | △37 |
投資その他の資産合計 | 599 | 584 |
固定資産合計 | 2,067 | 1,947 |
資産合計 | 10,140 | 10,244 |
| | (単位:百万円) |
| 前連結会計年度 (2025年7月31日) | 当連結会計年度 (2026年7月31日) |
負債の部 | | |
流動負債 | | |
買掛金 | 203 | 273 |
短期借入金 | 405 | 860 |
1年内返済予定の長期借入金 | 208 | 114 |
1年内償還予定の社債 | 26 | 17 |
未払金 | 794 | 549 |
未払法人税等 | 126 | - |
未払消費税等 | 75 | - |
契約負債 | 163 | 263 |
賞与引当金 | 78 | 76 |
契約損失引当金 | 25 | - |
事業構造改革引当金 | - | 61 |
その他 | 890 | 649 |
流動負債合計 | 2,997 | 2,865 |
固定負債 | | |
社債 | 17 | - |
長期借入金 | 451 | 383 |
繰延税金負債 | 50 | 22 |
資産除去債務 | 14 | 15 |
固定負債合計 | 533 | 421 |
負債合計 | 3,530 | 3,287 |
純資産の部 | | |
株主資本 | | |
資本金 | 1,351 | 50 |
資本剰余金 | 1,351 | 2,653 |
利益剰余金 | 3,876 | 4,240 |
自己株式 | △1 | △1 |
株主資本合計 | 6,578 | 6,942 |
その他の包括利益累計額 | | |
為替換算調整勘定 | 19 | △15 |
その他の包括利益累計額合計 | 19 | △15 |
新株予約権 | 12 | 30 |
純資産合計 | 6,610 | 6,957 |
負債純資産合計 | 10,140 | 10,244 |
E3604649340プレミアアンチエイジング株式会社Premier Anti-Aging Co., Ltd.通期第1号参考様式 [日本基準](連結)Japan GAAPtrueCTECTE2025-08-012026-07-31FY2026-07-312024-08-012025-07-312025-07-311falsefalsefalse493402026-07-31jpcrp_cor:ReportableSegmentsMember493402026-07-31tse-acedjpfr-49340:AntiagingReportableSegmentsMember493402026-07-31tse-acedjpfr-49340:RecoveryReportableSegmentsMember493402026-07-31jpcrp_cor:ReconcilingItemsMember493402025-07-31jpcrp_cor:ReportableSegmentsMember493402025-07-31tse-acedjpfr-49340:AntiagingReportableSegmentsMember493402025-07-31tse-acedjpfr-49340:RecoveryReportableSegmentsMember493402025-07-31jpcrp_cor:ReconcilingItemsMember493402026-07-31jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember493402026-07-31jpcrp_cor:UnallocatedAmountsAndEliminationMember493402025-08-012026-07-31jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember493402025-08-012026-07-31jpcrp_cor:UnallocatedAmountsAndEliminationMember493402025-07-31jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember493402025-07-31jpcrp_cor:UnallocatedAmountsAndEliminationMember493402024-08-012025-07-31jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember493402024-08-012025-07-31jpcrp_cor:UnallocatedAmountsAndEliminationMember493402024-08-012025-07-31jpcrp_cor:ReconcilingItemsMember493402026-07-31jppfs_cor:SubscriptionRightsToSharesMember493402025-08-012026-07-31jppfs_cor:SubscriptionRightsToSharesMember493402025-07-31jppfs_cor:SubscriptionRightsToSharesMember493402024-07-31jppfs_cor:RetainedEarningsMember493402024-07-31jppfs_cor:TreasuryStockMember493402024-07-31jppfs_cor:ValuationAndTranslationAdjustmentsMember493402024-07-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember493402024-08-012025-07-31jppfs_cor:ShareholdersEquityMember493402024-08-012025-07-31jppfs_cor:CapitalStockMember493402024-08-012025-07-31jppfs_cor:CapitalSurplusMember493402024-08-012025-07-31jppfs_cor:RetainedEarningsMember493402024-08-012025-07-31jppfs_cor:TreasuryStockMember493402024-08-012025-07-31jppfs_cor:ValuationAndTranslationAdjustmentsMember493402024-08-012025-07-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember493402025-08-012026-07-31jpcrp_cor:ReportableSegmentsMember493402025-08-012026-07-31tse-acedjpfr-49340:AntiagingReportableSegmentsMember493402025-08-012026-07-31tse-acedjpfr-49340:RecoveryReportableSegmentsMember493402025-08-012026-07-31jpcrp_cor:ReconcilingItemsMember493402024-08-012025-07-31jpcrp_cor:ReportableSegmentsMember493402024-07-31jppfs_cor:CapitalSurplusMember493402024-08-012025-07-31tse-acedjpfr-49340:AntiagingReportableSegmentsMember493402024-08-012025-07-31tse-acedjpfr-49340:RecoveryReportableSegmentsMember493402026-07-31jppfs_cor:ValuationAndTranslationAdjustmentsMember493402026-07-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember493402026-07-31jppfs_cor:ShareholdersEquityMember493402026-07-31jppfs_cor:TreasuryStockMember493402026-07-31jppfs_cor:RetainedEarningsMember493402026-07-31jppfs_cor:CapitalSurplusMember493402026-07-31jppfs_cor:CapitalStockMember493402025-08-012026-07-31jppfs_cor:ValuationAndTranslationAdjustmentsMember493402025-08-012026-07-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember493402025-08-012026-07-31jppfs_cor:ShareholdersEquityMember493402025-08-012026-07-31jppfs_cor:TreasuryStockMember493402025-08-012026-07-31jppfs_cor:RetainedEarningsMember493402025-08-012026-07-31jppfs_cor:CapitalSurplusMember493402025-08-012026-07-31jppfs_cor:CapitalStockMember493402025-07-31jppfs_cor:ValuationAndTranslationAdjustmentsMember493402025-07-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember493402025-07-31jppfs_cor:ShareholdersEquityMember493402025-07-31jppfs_cor:TreasuryStockMember493402025-07-31jppfs_cor:RetainedEarningsMember493402025-07-31jppfs_cor:CapitalSurplusMember493402025-07-31jppfs_cor:CapitalStockMember493402026-09-14493402026-07-31493402025-08-012026-07-31493402025-07-31493402024-08-012025-07-31493402024-07-31493402024-07-31jppfs_cor:ShareholdersEquityMember493402024-07-31jppfs_cor:CapitalStockMember493402024-07-31jppfs_cor:SubscriptionRightsToSharesMember493402024-08-012025-07-31jppfs_cor:SubscriptionRightsToSharesMemberiso4217:JPYxbrli:pure